Avoid Fraud, Get The Facts, And Find The Best
Legal Name: ORBIMED ADVISORS LLC
Period of report:
Jun 30, 2019
Effectiveness Date:
Aug 14, 2019
Security |
Shares Held / Principal Amount |
Market Value |
Option |
ASCENDIS PHARMA A S (04351P101)
|
3,846,673 |
$442,944k |
|
TRICIDA INC (89610F101)
|
11,114,280 |
$438,569k |
|
BOSTON SCIENTIFIC (101137107)
|
6,752,500 |
$290,222k |
|
ALEXION PHARMACEUTICALS INC CO (015351109)
|
1,926,085 |
$252,279k |
|
ALECTOR INC (014442107)
|
13,182,329 |
$250,464k |
|
MERCK & CO INC (58933Y105)
|
2,570,100 |
$215,503k |
|
PREVAIL THERAPEUTICS INC COM (74140Y101)
|
13,822,463 |
$182,457k |
|
Vertex Pharmaceuticals Inc (92532F100)
|
973,300 |
$178,484k |
|
Neurocrine Biosciences Inc. (64125C109)
|
1,833,200 |
$154,777k |
|
Iovance Biotherapeutics Inc (462260100)
|
5,548,326 |
$136,045k |
|
Thermo Fisher Scientific Inc (883556102)
|
462,800 |
$135,915k |
|
EDWARDS LIFESCIENCE (28176E108)
|
715,000 |
$132,089k |
|
Sarepta Therapeutics Inc (803607100)
|
828,400 |
$125,875k |
|
WRIGHT MEDICAL GROUP NV (NE) (N96617118)
|
4,187,799 |
$124,880k |
|
INTUITIVE SURGIC INC (46120E602)
|
210,300 |
$110,313k |
|
TURNING POINT THERAPEUTICS I (90041T108)
|
2,567,550 |
$104,499k |
|
ANTHEM INC (036752103)
|
361,600 |
$102,047k |
|
BAUSCH HEALTH COMPAN (071734107)
|
3,740,700 |
$94,340k |
|
PTC THERAPEUTICS INC (69366J200)
|
2,089,700 |
$94,037k |
|
INSPIRE MED SYS INC COM (457730109)
|
1,471,000 |
$89,216k |
|
NATERA INC (632307104)
|
3,224,328 |
$88,927k |
|
LOGICBIO THERAPEUTICS INC (54142F102)
|
6,466,783 |
$84,068k |
|
EXELIXIS INC (30161Q104)
|
3,912,900 |
$83,619k |
|
AVEDRO INC COM (05355N109)
|
4,240,128 |
$83,276k |
|
DECIPHERA PHARMACEUTICALS IN (24344T101)
|
3,618,171 |
$81,590k |
|
ABBOTT LABS (002824100)
|
938,000 |
$78,886k |
|
EHEALTH INC COM (28238P109)
|
909,814 |
$78,335k |
|
ATHENEX INC (04685N103)
|
3,840,130 |
$76,035k |
|
SYNTHORX INC (87167A103)
|
5,316,355 |
$71,824k |
|
UNIQURE N.V. (N90064101)
|
897,800 |
$70,163k |
|
MEIRAGTX HOLDINGS PLC (G59665102)
|
2,586,951 |
$69,537k |
|
Regeneron Pharmaceuticals Inc (75886F107)
|
215,800 |
$67,545k |
|
AGILENT TECHNOLOGIES INC (00846U101)
|
893,200 |
$66,695k |
|
AUDENTES THERAPEUTICS INC COM (05070R104)
|
1,713,069 |
$64,857k |
|
ARVINAS INC (04335A105)
|
2,678,810 |
$58,907k |
|
PRINCIPIA BIOPHARMA INC (74257L108)
|
1,605,713 |
$53,294k |
|
Illumina Inc (452327109)
|
140,200 |
$51,615k |
|
CRINETICS PHARMACE (22663K107)
|
2,039,282 |
$50,982k |
|
RESTORBIO INC (76133L103)
|
4,830,387 |
$49,270k |
|
MYOKARDIA INC (62857M105)
|
955,300 |
$47,899k |
|
VIEWRAY INC COM (92672L107)
|
5,149,019 |
$45,363k |
|
Argenx SE Sponsored ADR (04016X101)
|
310,400 |
$43,946k |
|
ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (98887Q104)
|
1,169,000 |
$40,763k |
|
NEXTCURE INC (65343E108)
|
2,711,013 |
$40,611k |
|
CIGNA CORP (125523100)
|
252,600 |
$39,797k |
|
DEXCOM INC (252131107)
|
262,900 |
$39,393k |
|
TANDEM DIABETES CARE (875372203)
|
570,790 |
$36,827k |
|
PROTHENA CORP PLC (G72800108)
|
3,065,278 |
$32,400k |
|
HARPOON THERAPEUTICS INC (41358P106)
|
2,446,409 |
$31,803k |
|
CAREDX INC COM (14167L103)
|
827,600 |
$29,785k |
|
OBSEVA SA (H5861P103)
|
2,605,531 |
$29,469k |
|
SPDR S&P 500 ETF TR TR UNIT (78462F103)
|
100,000 |
$29,300k |
Put |
CLOVIS ONCOLOGY INC COM (189464100)
|
1,913,234 |
$28,450k |
|
XTANT MED HLDGS INC (98420P308)
|
9,207,012 |
$27,621k |
|
MYLAN N V (n59465109)
|
1,373,305 |
$26,148k |
|
KRYSTAL BIOTECH INC (501147102)
|
642,006 |
$25,854k |
|
ENDO INTL PLC (G30401106)
|
6,165,464 |
$25,402k |
|
CORVUS PHARMACEUTICALS INC (221015100)
|
6,565,685 |
$24,556k |
|
ADVERUM BIOTECHNOLOGIES INC (00773U108)
|
1,960,200 |
$23,307k |
|
AURINIA PHARMACEUTICALS INC (05156V102)
|
3,531,002 |
$23,234k |
|
Bristol-Myers Squibb Co (110122108)
|
500,000 |
$22,675k |
Call |
SPARK THERAPEUTICS INC (84652J103)
|
219,900 |
$22,513k |
|
AMGEN INC (031162100)
|
122,100 |
$22,501k |
|
GENFIT SA ADR (372279109)
|
1,125,607 |
$22,231k |
|
Kala Pharmaceuticals, Inc. (483119103)
|
3,447,840 |
$21,997k |
|
ALCON INC (H01301128)
|
351,380 |
$21,682k |
|
BIOGEN INC (09062X103)
|
87,700 |
$20,510k |
|
SI BONE INC COM (825704109)
|
985,368 |
$20,042k |
|
KARYOPHARM THERAPEUTICS INC (48576U106)
|
3,148,475 |
$18,859k |
|
SYNLOGIC INC (87166L100)
|
2,029,996 |
$18,473k |
|
TAKEDA PHARMACEUTICAL CO LTD (874060205)
|
1,000,000 |
$17,700k |
Call |
Rhythm Pharmaceuticals, Inc. (76243J105)
|
787,300 |
$17,321k |
|
VERRICA PHARMACEUTICALS INC (92511W108)
|
1,479,733 |
$17,194k |
|
NOVO-NORDISK AS (670100205)
|
330,000 |
$16,843k |
|
SINOVAC BIOTECH LTD (P8696W104)
|
2,839,500 |
$16,611k |
|
Alpine Immune Sciences Inc (02083G100)
|
3,670,955 |
$15,455k |
|
AEGLEA BIOTHERAPEUTICS INC (00773J103)
|
2,165,524 |
$14,834k |
|
ABBVIE INC (00287Y109)
|
200,000 |
$14,544k |
Call |
X4 PHARMACEUTICALS INC (98420X103)
|
936,493 |
$14,047k |
|
B. Riley Wealth Management, Inc. (023111206)
|
717,600 |
$13,914k |
|
PROQR THRAPEUTICS N V (N71542109)
|
1,382,502 |
$12,581k |
|
FOAMIX PHARMACUTICLS (M46135105)
|
5,195,330 |
$12,365k |
|
IMMUNOMEDICS INC (452907108)
|
818,200 |
$11,348k |
|
NABRIVA THERAPEUTICS PLC SHS (G63637105)
|
4,644,600 |
$11,286k |
|
STRYKER CORP (863667101)
|
54,000 |
$11,101k |
|
ARQULE INC (04269E107)
|
1,000,000 |
$11,010k |
|
SCPHARMACEUTICALS INC (810648105)
|
3,409,865 |
$10,877k |
|
PFIZER INC (717081103)
|
250,000 |
$10,830k |
Put |
CONSTELLATION PHARMCETICLS I (210373106)
|
835,842 |
$10,264k |
|
Reata Pharmaceuticals Inc. (75615P103)
|
100,000 |
$9,435k |
Put |
PERSONALIS INC (71535D106)
|
300,000 |
$8,145k |
|
PUMA BIOTECHNOLOGY INC (74587V107)
|
624,249 |
$7,934k |
|
MERSANA THERAPEUTICS INC (59045L106)
|
1,891,119 |
$7,659k |
|
Assembly Biosciences Inc (045396108)
|
523,600 |
$7,063k |
|
GILEAD SCIENCES INC (375558103)
|
100,000 |
$6,756k |
Call |
AMICUS THERAPEUTICS INC (03152W109)
|
518,309 |
$6,468k |
|
ARENA PHARMACEUTICALS INC COM NEW (040047607)
|
110,000 |
$6,449k |
|
BIOMARIN PHARMACEUTICAL INC (09061G101)
|
75,000 |
$6,424k |
Put |
VERONA PHARMA PLC (925050106)
|
1,250,396 |
$6,377k |
|
XENON PHARMACEUTICALS INC (98420N105)
|
634,812 |
$6,259k |
|
SPERO THERAPEUTICS INC (84833T103)
|
507,471 |
$5,841k |
|
ADAPTIVE BIOTECHNOLOGIES COR (00650F109)
|
120,000 |
$5,796k |
|
MEDICINES CO (584688105)
|
151,515 |
$5,526k |
|
ADAPTIMMUNE THERAPEUTICS PLC (00653A107)
|
1,350,655 |
$5,430k |
|
Intellia Therapeutics Inc (45826J105)
|
327,600 |
$5,363k |
|
SELECTA BIOSCIENCES INC (816212104)
|
2,879,064 |
$5,154k |
|
Ultragenyx Pharmaceutical Inc (90400D108)
|
79,607 |
$5,055k |
|
AERPIO PHARMACEUTICALS INC (00810B105)
|
5,193,946 |
$4,726k |
|
CTI BIOPHARMA CORP (12648L601)
|
5,000,000 |
$4,297k |
|
MENLO THERAPEUTICS (586858102)
|
673,700 |
$4,035k |
|
STOKE THERAPEUTICS INC COM (86150R107)
|
130,000 |
$3,792k |
|
NOVUS THERAPEUTICS INC (67011N105)
|
3,183,314 |
$3,215k |
|
REALM THERAPEUTICS PLC (75606L103)
|
1,021,484 |
$2,870k |
|
ACADIA PHARMACEUTCLS (004225108)
|
101,900 |
$2,724k |
|
DYNAVAX TECHNOLOGIES CORP (268158201)
|
583,500 |
$2,328k |
|
SYNDAX PHARMACEUTICALS INC (87164F105)
|
212,000 |
$1,974k |
|
APELLIS PHARMACEUTICALS INC (03753U106)
|
75,000 |
$1,901k |
Call |
AVROBIO INC (05455M100)
|
106,000 |
$1,724k |
|
MARINUS PHARMACEUTICALS INC CO (56854Q101)
|
398,101 |
$1,652k |
|
NUVECTRA CORP (67075N108)
|
350,000 |
$1,173k |
|
FLEXION THERAPEUTICS INC COM (33938J106)
|
89,919 |
$1,106k |
|
BIOLINERX LTD (09071M106)
|
1,038,600 |
$379k |
|
MEDIGUS LTD (58471G300)
|
15,000 |
$37k |
|
Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.
All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.
Recently Searched Firms
Please note: Search data is accumulated by 3rd party and refreshed once per day.